Moreover, the diagnostic accuracies of SCAND3 and Myo1g methylation in AFP-negative HCC patients were excellent, and “SCAND3 + Myo1g” showed the best sensitivity of 92%, with an AUC of 0.857 (0.799–0.916). This evidence concerns the gene MYO1G and hepatocellular carcinoma.